Dr. Susanne Petri Joins NDR Scientific Group

NDR Inc is pleased to announce that Dr. Susanne Petri has joined our scientific group. Dr. Petri is an Associate Professor in the Department of Neurology at the Hannover Medical School in Hannover, Germany, and has published over 10 important papers in the ALS field in the past 5 years.


Her studies center on using patient-derived induced pluripotent stem cells, iPSC, and using these cells to analyze therapeutics for ALS patients. She published her work on the roles of ALS-associated toxic proteins in cell culture and mouse models and she studied the role of altered calcium dynamics and glutamate receptors in iPSCs from patients with ALS.


She published several genetic studies as well as clinical trials testing the safety and effectiveness of levosimendan in ALS patients. She studies gene variants in ALS patients. She brings her expertise in culturing induced motor neurons and therapeutics to our discovery program.


NDR funded a two-year program that will investigate the therapeutic potential of drug interventions on the microglia in ALS.

9 views0 comments

Recent Posts

See All

We are pleased to announce that Dr. Steve Pelech, Kinexus Bioinformatics Corp, completed a long time goal with funding help from NDR. Steve developed a suite of 230 rabbit polyclonal, affinity-purifie

We are pleased to let you hear Dr. Sayuri Myiamoto present her preliminary work, listen to the video. There is a lot more to learn, and her lab is working on the next steps. She is publishing her no